Optimise efficiency of your gene therapy or vaccine development

Viral capsids like the lentivirus, rAAV and Adenovirus vectors are increasingly used as vectors in gene therapy and vaccines (including those for Covid-19). To develop efficient virally-vectored therapies, extensive characterisation needs to be done from measuring capsid size & count, % full, aggregate formation, stability, genome release and capsid charge.  Join this webinar series of “Ask an Expert”  Expand your application knowledge of various techniques from Dynamic Light Scattering (DLS), Differential Scanning Calorimetry (DSC), Nanoparticle Tracking Analysis (NTA) and multi-detection SEC (SEC-MALS)  Learn using case study examples and analysis REGISTER FOR THE LIVE WEBINARS OR TO RECEIVE A RECORDING    Webinar 1: Efficient development of gene therapy and vaccines through comprehensive viral vector characterisation. REGISTER HERE Webinar 2: Quantifying rAAV with Multi-angle DLS and nanoparticle tracking analysis.  REGISTER HERE   Webinar 3: Optimising loading time and stability of Virally Vectored therapies and vaccines using SEC and DSC.  REGISTER HERE Complementary technologies for enhanced characterisation and generation of multi-parametral stability profile of rAAV samples. WATCH NOW

Contact us for a demo Request a quote now Email us for more info